RemeGen
688331119.603.16% ( -3.90 )
RemeGen (688331)
RemeGen Co., Ltd., a biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, an...
- Open
- 122.00
- High
- 123.95
- Low
- 118.70
- Prev. Close
- 123.50
- Volume
- 48.36K
- Turnover
- 583.68M
- Avg Price
- 120.70
- Bid/Ask Ratio
- --
- Amplitude
- 4.25%
- 52wk High
- 157.80
- Volume Ratio
- 0.47
- Turnover Ratio
- 1.36%
RemeGen Analyst Rating
View MoreForecast & Rating
Jul 24, 2026Price forecast
¥138.3615.69%
Forecast & RatingBuy
6analysts
- Strong buy50.00%
- Buy16.67%
- Hold33.33%
- Sell0.00%
- Strong sell0.00%
News
- AASTOCKS News · 1 day ago, 02:37 AM
Nomura Raises REMEGEN TP to HKD89.44, Maintains Neutral Rating
- Tip Ranks · Jul 2 at 07:38 AM
RemeGen Deploys Idle Funds Into SPDB Wealth Products in Discloseable Transaction
- Tip Ranks · Jun 16 at 09:39 AM
RemeGen Clarifies Board Composition and Committee Roles
- StockTitan · Jun 7 at 11:31 PM
Telitacicept Receives NMPA Approval for the Treatment of Sjögren’s Disease in China | VOR Stock News
- 同壁财经 · Jun 1 at 08:50 PM
Breaking! Akeso plummets 8% during trading! Hwabao WP Hang Seng SCHK Innovative Drug Select ETF (520880) falls over 2.5% to set a new historical low
- AASTOCKS News · May 29 at 02:32 AM
M Stanley Ratings and TPs on China Biotech Stocks
